Secondary |
Product Used For Unknown Indication |
51.7% |
Drug Use For Unknown Indication |
15.2% |
Thrombosis Prophylaxis |
5.5% |
Constipation |
4.1% |
Induction Of Anaesthesia |
2.1% |
Insomnia |
2.1% |
Pain |
2.1% |
Pharyngitis |
2.1% |
Systemic Lupus Erythematosus |
2.1% |
Abnormal Faeces |
1.4% |
Benign Prostatic Hyperplasia |
1.4% |
Bone Disorder |
1.4% |
Dyspepsia |
1.4% |
Hypertension |
1.4% |
Maintenance Of Anaesthesia |
1.4% |
Red Blood Cell Abnormality |
1.4% |
Thyroid Disorder |
1.4% |
Bipolar I Disorder |
0.7% |
Chronic Obstructive Pulmonary Disease |
0.7% |
Gastrooesophageal Reflux Disease |
0.7% |
|
Deep Vein Thrombosis |
32.0% |
Incontinence |
8.0% |
Bipolar I Disorder |
4.0% |
Cardiac Arrest |
4.0% |
Chronic Hepatic Failure |
4.0% |
Completed Suicide |
4.0% |
Confusional State |
4.0% |
Death |
4.0% |
Dyskinesia |
4.0% |
Dyspnoea |
4.0% |
Functional Gastrointestinal Disorder |
4.0% |
Macule |
4.0% |
Maternal Drugs Affecting Foetus |
4.0% |
Normal Newborn |
4.0% |
Prostatic Disorder |
4.0% |
Serotonin Syndrome |
4.0% |
Vomiting |
4.0% |
|
Concomitant |
Product Used For Unknown Indication |
40.1% |
Constipation |
9.7% |
Pain |
9.6% |
Drug Use For Unknown Indication |
6.2% |
Nausea |
5.3% |
Multiple Myeloma |
5.0% |
Hypertension |
3.2% |
Depression |
2.9% |
Schizophrenia |
2.8% |
Prophylaxis |
2.1% |
Breast Cancer |
1.9% |
Anxiety |
1.5% |
Diabetes Mellitus |
1.4% |
Abdominal Pain |
1.3% |
Acute Myeloid Leukaemia |
1.3% |
Asthma |
1.3% |
Paroxysmal Nocturnal Haemoglobinuria |
1.2% |
Insomnia |
1.1% |
Supplementation Therapy |
1.1% |
Vomiting |
1.1% |
|
Death |
9.7% |
Pyrexia |
8.3% |
Dyspnoea |
6.3% |
Neutropenia |
6.3% |
Hallucination, Visual |
5.6% |
Haemoglobin Decreased |
4.9% |
Multiple Myeloma |
4.9% |
Myocardial Infarction |
4.9% |
Staphylococcal Infection |
4.9% |
Cerebrovascular Accident |
4.2% |
Colitis |
4.2% |
Fall |
4.2% |
Febrile Neutropenia |
4.2% |
Haematemesis |
4.2% |
Nausea |
4.2% |
Pain |
4.2% |
Thrombocytopenia |
4.2% |
Vomiting |
4.2% |
Asthenia |
3.5% |
Dizziness |
3.5% |
|